vaccine production

...Genject brand disposable vaccine syringes are produced untouched by hand in accordance with ISO 13485 and CE standards in the new production facility in a closed area of 18,000 m², equipped with 2021 model machinery and state-of-the-art technology. Genject brand vaccine syringes have a shelf life of 5 years with ethylene oxide (EO) gas sterilization method. It is non-toxic and pyrogen-free with...

... with its high water retention property. While effective in increasing collagen levels, it also fights against potential problems and irritations on the skin. Peptides: Peptides are proteins that help increase the decreasing amount of collagen in the body over time. By combating aging and wear, they increase collagen production and moisture balance. Olus Oil: Plant-based emollient. Hypoallergenic, making it suitable for those with the driest and most sensitive skin types.

... eliminate the cold chain and storage problems in order to reach all Covid19 vaccines developed in the World to the end user in a healthy way. These developments include mobile container type vaccine cold storage and fixed logistic vaccine storages. We offer turnkey solutions for all institutions such as healthcare institutions, hospitals, laboratories, logistics warehouses, pharmaceutical companies, and research institutions that need these special cold storages. You can contact us for details.

...Excellence in pharmaceutical TOC ultrapure water analysis and quality control of vaccines The TN analyzer with catalytic high-temperature combustion and CLD detection for efficient protein analysis in vaccine production or TN cleaning validation with minimal sample consumption and high degree of automation. Characteristics of the multi N/C 2100S pharma: • No sample carryover due to septum-free...

...Rare sugars are naturally occurring sugars produced from sustainable wood or other biomass hydrolysates using an aqueous chromatographic, solvent-free separation process. Rare sugars can be used in medicine as nutrients for cell cultures in vaccine production. This product has high chiral purity and is utilized in the pharmaceutical, cosmetic, food, and flavor industries due to its moisturizing...

... are 100% CIP-SIP capable. • Safe separation of hostile media. Examples of: • Influenza vaccine production. • Hepatitis vaccine production. • Recombinant protein production. • Cultivation of cell bank strains and viability tests.

...LPS-BioSciences uses its exclusive phenol-free method to extract lipopolysaccharides (LPS) from Gram-negative bacteria. We are able to provide you with ultra-pure LPS thanks to our unique extraction method, which can be tailored to your needs. This may involve producing bacterial adjuvants such as LPS or PS, LTA, CAPS, TA for your vaccine applications or your research in the infectious field.

... proteins for the pharmaceutical industry. - Bacteria and viruses for vaccine production in the industry. A good supply of nutrients to the cells, consistent temperature distribution, and optimal aeration of the cells during cell cultivation are crucial criteria for the optimal growth of the cells. Whether shear-sensitive cell types with special requirements or more robust cells, medorex bioreactors offer optimal, precise, and reproducible cultivation and...

...laboratory autoclaves, laminar flow hoods, reverse osmosis systems, culture medium preparators, fillers for industrial and laboratory automatic cultures for containers and Petri dishes, and industrial lines for vaccine production.

DOLLVET company for veterinary vaccine production and biological materials. Located in Turkey, it produces a wide range of veterinary vaccines for farm animals, fertilizers, and fish vaccines. We won the European Union tender in 2009 and became the official supplier for the EU. All our products comply with OIE requirements, in addition to direct inspections by the Turkish authorities.

... RNA, or for vaccine purposes. We have also developed an innovative and patented technology (Staby®) for the antibiotic-free bioproduction of plasmids and recombinant proteins in E. coli cells. Our technology significantly increases the stability of plasmid DNA in host strains, resulting in an overall improvement in production yield and reproducibility. It serves as a good alternative to standard antibiotic resistance genes and meets regulatory demands. Please feel free to contact us for more information!

CELLON SA is a company specialized in products and services for the biopharmaceutical sector and the biochemical industry (vaccine production), as well as in 3D tissue culture research. General equipment for pharmaceutical laboratories and biochemical labs, sterilizers for laboratories, machines and equipment for packaging sterile liquids, filling and dosing of liquid, pasty, viscous, and semi...